Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid

New England Journal of Medicine

Volumn 330, Issue 25, 1994, Pages 1789-1790

  Saba, Hussain I ^a   Morelli, Genevieve A ^b   Logrono, Luis A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 8; DILTIAZEM; FERROUS SULFATE; GLYCERYL TRINITRATE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY ANEMIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; RENDU OSLER WEBER DISEASE; SUBLINGUAL DRUG ADMINISTRATION;

AGED; AMINOCAPROIC ACIDS; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 0028290625     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199406233302504     Document Type: Article

References (30)

1. Hanes FM Multiple hereditary telangiectases causing hemorrhage (hereditary hemorrhagic telangiectasia). Bull Johns Hopkins Hosp 1909; 20: 63-73
2. Bird RM, Hammarsten JF, Marshall RA, Robinson RR A family reunion: a study of hereditary hemorrhagic telangiectasia. N Engl J Med 1957; 257: 105-109
3. Osler W On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Bull Johns Hopkins Hosp 1901; 12: 333-337
4. Peery WH Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1987; 82: 989-997
5. Plauchu H, de Chadarevian JP, Bideau A, Robert JM Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32: 291-297
6. Zohar Y, Sadov R, Shvili Y, Talmi Y, Laurian N Surgical management of epistaxis in hereditary hemorrhagic telangiectasia. Arch Otolaryngol Head Neck Surg 1987; 113: 754-757
7. McCabe WP, Kelly AP Jr Management of epistaxis in Osler-Weber-Rendu disease: recurrence of telangiectases within a nasal skin graft. Plast Reconstr Surg 1972; 50: 114-118
8. Harrison DF Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope 1982; 92: 314-320
9. Van Cutsem E, Rutgeerts P, Geboes K, Van Gompel F, Vantrappen G Estrogen-progesterone treatment of Osler-Weber-Rendu disease. J Clin Gastroenterol 1988; 10: 676-679
10. Ablondi FB, De Renzo EC Mechanism of clot lysis by streptokinase and effects of epsilon-aminocaproic acid. Proc Soc Exp Biol Med 1959; 102: 717-719
11. Alkjaersig N, Fletcher AP, Sherry S epsilon-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem 1959; 234: 832-837
12. Hardy JF, Desroches J Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 1992; 39: 353-365
13. Vander Salm TJ, Ansell JE, Okike ON, The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study. J Thorac Cardiovasc Surg 1988; 95: 538-540
14. Singh I, Laungani GB Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage. Urology 1992; 40: 227-229
15. Stefanini M, English HA, Taylor AE Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract. J Urol 1990; 143: 559-561
16. Jash DK Epistaxis — topical use of epsilon-aminocaproic acid in its management. J Laryngol Otol 1973; 87: 895-898
17. Hashimoto K, Pritzker MS Hereditary hemorrhagic telangiectasia: an electron microscopic study. Oral Surg Oral Med Oral Pathol 1972; 34: 751-768
18. Jahnke V Ultrastructure of hereditary telangiectasia. Arch Otolaryngol 1970; 91: 262-265
19. Muckle TJ Low in-vivo adhesive-platelet count in hereditary haemorrhagic telangiectasia. Lancet 1964; 2: 880-882
20. Larsson SO Osler's disease with impaired adhesion and aggregation of platelets. Acta Med Scand 1974; 196: 133-136
21. Endo Y, Mamiya S, Niitsu H, Miura A, Nishimura S Reduced platelet aggregation induced by epinephrine and idiopathic thrombocytopenic purpura in hereditary haemorrhagic telangiectasia. Thromb Haemost 1984; 52: 369-369
22. Pandolfi M, Ehinger B Conjunctival bleeding in Osler's disease with associated platelet dysfunction: a case report. Acta Ophthalmol (Copenh) 1978; 56: 75-82
23. Conlon CL, Weinger RS, Cimo PL, Moake JL, Olson JD Telangiectasia and von Willebrand's disease in two families. Ann Intern Med 1978; 89: 921-924
24. Hanna W, McCarroll D, Lin D, A study of a Caucasian family with variant von Willebrand's disease in association with vascular telangiectasia and haemoglobinopathy. Thromb Haemost 1984; 51: 275-278
25. Sudarshan A, Natelson EA, Gordon C Hereditary hemorrhagic telangiectasia and factor VIII inhibitor. South Med J 1985; 78: 623-624
26. Gola A, Kotschy M, Nowicka J, Kaiser A Ein Fall von Morbus Osler mit gleichzeitig bestehender Thrombozytopenie und einem Faktor VIII-Inhibitor. Folia Haematol Int Mag Klin Morphol Blutforsch 1977; 104: 102-108
27. Steel D, Bovill EG, Golden E, Tindle BH Hereditary hemorrhagic telangiectasia: a family study. Am J Clin Pathol 1988; 90: 274-278
28. Sureda A, Cesar J, Garcia Frade LJ, Garcia Avello A, Fernandez Fuertes I, Navarro JL Hereditary hemorrhagic telangiectasia: analysis of platelet aggregation and fibrinolytic system in seven patients. Acta Haematol 1991; 85: 119-123
29. Kwaan HC, Silverman S Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasia. Arch Dermatol 1973; 107: 571-573
30. Watanabe M, Hanawa S, Morishima T. Fibrinolytic activity in cutaneous lesions of hereditary hemorrhagic telangiectasia. Nippon Hifuka Gakkai Zasshi 1985;95:11-6. (In Japanese).